143 related articles for article (PubMed ID: 14991995)
1. [Antagonistic effect of myricetin on platelet activing factor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Yao Xue Xue Bao; 2003 Nov; 38(11):831-3. PubMed ID: 14991995
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
[TBL] [Abstract][Full Text] [Related]
3. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
[TBL] [Abstract][Full Text] [Related]
4. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
5. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
Herbert JM; Laplace MC; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
[TBL] [Abstract][Full Text] [Related]
7. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
8. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
Zeng S; Guo ZG
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
11. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
Zhang M; Zhang LZ; Lu JS
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
[TBL] [Abstract][Full Text] [Related]
12. PAF binding to a single receptor in corneal epithelium plasma membrane.
Hurst J; Ma X; Bazan HE
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
Wang XD; Bian RL
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
[TBL] [Abstract][Full Text] [Related]
14. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
Herbert JM; Laplace MC; Cailleau C; Maffrand JP
J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255
[TBL] [Abstract][Full Text] [Related]
15. Piperbetol, methylpiperbetol, piperol A and piperol B: a new series of highly specific PAF receptor antagonists from Piper betle.
Zeng HW; Jiang YY; Cai DG; Bian J; Long K; Chen ZL
Planta Med; 1997 Aug; 63(4):296-8. PubMed ID: 9270371
[TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1989 Jul; 250(1):293-300. PubMed ID: 2545861
[TBL] [Abstract][Full Text] [Related]
18. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits].
Chen WM; Jin M; Wu W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Apr; 22(4):283-5. PubMed ID: 12584792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]